Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Sun Pharma Advanced Research Company Limited (SPARC.NS)

NSE - NSE Real Time Price. Currency in INR
179.35+1.45 (+0.82%)
At close: 03:30PM IST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in INR

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/2/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.74
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3305.85
52 Week Low 3162.10
50-Day Moving Average 3188.27
200-Day Moving Average 3216.51

Share Statistics

Avg Vol (3 month) 3997.5k
Avg Vol (10 day) 33.3M
Shares Outstanding 5324.52M
Implied Shares Outstanding 6N/A
Float 877.94M
% Held by Insiders 164.90%
% Held by Institutions 11.36%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2022
Most Recent Quarter (mrq)Sep 30, 2022

Profitability

Profit Margin -161.23%
Operating Margin (ttm)-155.08%

Management Effectiveness

Return on Assets (ttm)-48.58%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)1.47B
Revenue Per Share (ttm)5.50
Quarterly Revenue Growth (yoy)13.20%
Gross Profit (ttm)1.1B
EBITDA -2.2B
Net Income Avi to Common (ttm)-2.38B
Diluted EPS (ttm)-7.40
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)41.9M
Total Cash Per Share (mrq)0.15
Total Debt (mrq)1.93B
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.22
Book Value Per Share (mrq)-1.79

Cash Flow Statement

Operating Cash Flow (ttm)-1.8B
Levered Free Cash Flow (ttm)-1.31B
Advertisement
Advertisement